Versatile Chitosan‐Based Hydrogel Dressings for Multi‐Scenario Wound Management

Why It Matters

Integrating multiple therapeutic actions into a single dressing could lower treatment costs and improve outcomes for complex wounds, a growing burden in aging and diabetic populations.

Key Takeaways

• Dynamic covalent bonds enable self‑healing hydrogel structure.
• Intrinsic chitosan provides hemostatic and antimicrobial activity.
• Stimuli‑responsive release targets pH, temperature, glucose cues.
• Effective in acute wounds and chronic diabetic ulcers.
• Promotes vascular regeneration and macrophage polarization.

Pulse Analysis

Hydrogel dressings have emerged as a versatile platform for wound care because they mimic the extracellular matrix, maintain a moist environment, and allow gas exchange. Chitosan, a naturally derived polysaccharide, brings inherent biocompatibility, oxygen permeability, hemostasis, and broad‑spectrum antimicrobial activity. When incorporated into a hydrogel network, these properties are amplified, offering a scaffold that can conform to irregular wound geometries while delivering bioactive agents directly to the injury site.

The latest generation of chitosan hydrogels leverages reversible cross‑linking mechanisms such as Schiff‑base formation, borate‑diol coordination, and host‑guest interactions. These dynamic bonds grant the material self‑healing capability, enabling the dressing to recover from mechanical stress without losing integrity. Coupled with non‑covalent forces like hydrogen bonding and electrostatic attraction, the network can be tuned for stimulus‑responsive behavior—releasing antibiotics, growth factors, or antioxidants in response to pH shifts, temperature changes, or glucose levels. This multifunctional approach addresses the sequential phases of wound healing, from rapid hemostasis to inflammation control and tissue remodeling.

Clinically, the ability to treat both acute injuries and chronic conditions such as diabetic foot ulcers or burn wounds in a single platform could transform wound management. By reducing infection rates, accelerating vascularization, and modulating immune responses, chitosan‑based hydrogels promise lower hospitalization costs and improved patient quality of life. Ongoing challenges include large‑scale manufacturing, regulatory approval, and long‑term safety validation, but the convergence of material science and biomedical engineering positions these dressings for rapid adoption in the next decade.